BIScreener: enhancing breast cancer ultrasound diagnosis through integrated deep learning with interpretability.
Authors
Affiliations (4)
Affiliations (4)
- Hunan Key Lab of Biomedical Materials and Devices, College of Life Sciences and Chemistry, Hunan University of Technology, Zhuzhou, 412007, PR China.
- State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, China. [email protected].
- Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, 412000, PR China.
- Hunan Province Directly Affiliated TCM Hospital, Zhuzhou, 412000, PR China. [email protected].
Abstract
Breast cancer is the leading cause of death among women worldwide, and early detection through the standardized BI-RADS framework helps physicians assess the risk of malignancy and guide appropriate diagnostic and treatment decisions. In this study, an interpretable deep learning model (BIScreener) was proposed for predicting BI-RADS classifications from breast ultrasound images, aiding in the accurate assessment of breast cancer risk and improving diagnostic efficiency. BIScreener utilizes the stacked generalization of three pretrained convolutional neural networks to analyze ultrasound images obtained from two specific instruments (Mindray R5 and HITACHI) used at local hospitals. BIScreener achieved a classification total accuracy of 90.0% and ROC-AUC value of 0.982 in the external test set for five BI-RADS categories. The proposed method achieved 83.8% classification total accuracy and 0.967 ROC-AUC value for seven BI-RADS categories. In addition, the model improved the diagnostic accuracy of two radiologists by more than 8.1% for five BI-RADS categories and by more than 4.8% for seven BI-RADS categories and reduced the explanation time by more than 19.0%, demonstrating its potential to accelerate and improve the breast cancer diagnosis process.